Idebenone enhances mitochondrial function by acting as an electron carrier in the mitochondrial respiratory chain, thereby increasing the production of ATP.
• Idebenone was developed by Takeda Pharmaceutical for the treatment of Alzheimer's disease and other cognitive defects
• Idebenone was approved for treatment of Leber's hereditary optic neuropathy (LHON) in the EU & UK in 2015.